Other exchanges or trading platforms where Scancell Holdings plc securities are admitted or traded:

Scancell Holdings securities are listed on AIM, and the latest share price is shown here

The number of securities in issue:

The company has an issued share capital of 818,403,461 ordinary shares of 0.1p each, all of which are called up and fully paid.

Directors’ Share Options:

The Company has granted the following options to Directors of the Company. 

Option holder          Option price per ordinary share Number of ordinary shares under option Last day of exercise period
Sally Adams 10.5p 2,500,000 30 January 2028
Sally Adams 8.15p 1,000,000 30 April 2030
Lindy Durrant 10.5p 9,000,000 30 January 2028
Lindy Durrant 8.15p 1,000,000 30 April 2030
Lindy Durrant 4.5p 3,850,000 30 July 2023
Lindy Durrant 21.36p 9,000,000 19 August 2031
Jean-Michel Cosséry 17.5p 3,000,000 20 April 2033
Susan Clement Davies 17.5p 1,000,000 20 April 2033

 

In addition to the above, the Company has granted options over 16,765,541 shares of the Company to various other persons at exercise prices between 5p and 33.2p.

Percentage of AIM securities not in public hands:

As at 18 May 2023 the percentage of AIM securities not in public hands was: 45.00%

Restrictions on the transfer of securities:

There are no restrictions on the transfer of shares.

Identity and percentage holdings of significant shareholders:

As at 18 May 2023 the identity and percentage holdings of significant shareholders were: 

  Ordinary shares at 0.1p each
  Number Percentage
Redmile Group LLC 240,374,384 29.37%
Vulpes Life Science Fund 117,729,029 14.39%
Calculus Capital 37,546,331 4.58%
Scancell Holdings plc directors and related holdings 10,133,222 1.24%